Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

23 Jul 2021 15:21

RNS Number : 3444G
Unicorn AIM VCT PLC
23 July 2021
 

 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 April 2021 to 30 June 2021

 

Introduction

 

This voluntary Interim Management Statement (IMS) covers the three month period ended 30 June 2021, together with relevant information up to the date of publication. 

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust ("VCT"), so that Shareholders benefit from the taxation advantages that this brings. To achieve this, at least 80% for accounting periods commencing on or after 6 April 2019 (previously 70%) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares, which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance  

The Company's portfolio of investments performed reasonably well with net asset value per share continuing to increase steadily over the quarter.

As at 30 June 2021, the unaudited net asset value was 247.6 pence per share, which represents an increase of +6.7% on the audited closing net asset value of 232.1 pence per share as at 31 March 2021. UK equity indices also continued their strong run, with the FTSE AIM All-Share Index generating a total return of +4.5%, while the FTSE All-Share Index delivered a total return of +5.6% over the same period.

The portfolio remains predominantly composed of investments in businesses listed on the Alternative Investment Market (AIM). A good number of these investee companies are relatively mature and, as such, most of these businesses have remained profitable, despite the difficulties posed by the ongoing COVID-19 pandemic.

The number and value of new VCT qualifying investments completed in the period was healthy and the pipeline of promising opportunities continues to strengthen. As a result, all key HMRC tests continue to be met. At the period end, an estimated 86.6% of total assets (assessed in accordance with VCT rules) was invested in VCT qualifying companies.

Despite the increased risks associated with early stage investment and the uncertainty created by the COVID-19 pandemic, the Investment Manager is confident that the portfolio, as a whole, has the potential to continue delivering attractive total returns over the longer term.

 

Material Transactions

During the period under review, four new VCT qualifying investments were completed, costing £9.2 million in total. One follow-on VCT qualifying investment was also made at a total cost of £0.5m.

Approximately £0.3 million was raised from the partial disposal of two holdings during the period. In addition, the Company's entire holding in Wey Education was sold, following a successful takeover bid from Inspired Education Group. This disposal realised proceeds of over £4.6 million and a capital profit of almost £2.5 million.

The purpose of disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to Shareholders via dividend payments, and to help manage liquidity requirements.

Top Ten VCT Qualifying Holdings as at 30 June 2021

Stock

% of fund

 

 

Interactive Investor

10.2%

Hasgrove

9.1%

Maxcyte

6.0%

Abcam

4.4%

Tracsis

4.1%

Renalytix AI

3.5%

Anpario

3.2%

Surface Transforms

3.0%

Tristel

2.8%

Augean

2.4%

 

 

Total

48.7%

 

Share Buy-Backs

 

During the period from 1 April to 30 June 2021, the Company bought back 592,273 of its own Ordinary Shares for cancellation, at a price of 210 pence per share. As at 30 June 2021, there were 149,758,626 Ordinary Shares in issue. After the period end, a further 293,191 Ordinary Shares were purchased for cancellation at a price of 215 pence per share.

 

Interim Dividend

As previously advised, the Board declared an interim dividend of 3.0 pence per share in respect of the Company's half year ended 31 March 2021. This interim dividend will be paid on 12 August 2021 to Shareholders who were on the register on 15 July 2021.

Issue of Equity

 

During the period, a total of 1,129,286 new Ordinary Shares were issued in the new tax year at prices ranging between 237.4p and 238.2p per share under the Offer for Subscription, which launched on 28 January 2021. The Offer closed on 11 February 2021 having raised approximately £15 million before costs.

Material Events

There were no material events during the period under review.

Chris Hutchinson

Director, Unicorn Asset Management

Investment Manager

 

23 July 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRMZGZNDFRGMZM
Date   Source Headline
4th Aug 201710:32 amRNSNet Asset Value(s)
25th Jul 20175:09 pmRNSOffer for Subscription and Issue of Prospectus
13th Jul 201712:17 pmRNSIntention to launch an Offer
5th Jul 20172:46 pmRNSNet Asset Value(s)
3rd Jul 201712:01 pmRNSTotal Voting Rights
9th Jun 20175:08 pmRNSTransaction in Own Shares
6th Jun 201712:19 pmRNSNet Asset Value(s)
1st Jun 201711:00 amRNSTotal Voting Rights
31st May 20177:00 amRNSHalf-year Report
10th May 20175:09 pmRNSTransaction in Own Shares
9th May 20175:15 pmRNSClosed Period Notification
5th May 201711:30 amRNSNet Asset Value(s)
2nd May 201710:28 amRNSTotal Voting Rights
7th Apr 20174:52 pmRNSTransaction in Own Shares
6th Apr 20172:54 pmRNSNet Asset Value(s)
3rd Apr 201710:58 amRNSTotal Voting Rights
8th Mar 20175:17 pmRNSTransaction in Own Shares
6th Mar 201710:18 amRNSNet Asset Value(s)
1st Mar 201710:31 amRNSTotal Voting Rights
16th Feb 20174:43 pmRNSTransaction in Own Shares
15th Feb 20175:44 pmRNSTransaction in Own Shares
10th Feb 20175:45 pmRNSDirector/PDMR Shareholding
9th Feb 20173:32 pmRNSTotal Voting Rights
8th Feb 20175:38 pmRNSIssue of Equity
6th Feb 20171:22 pmRNSNet Asset Value(s)
3rd Feb 20175:25 pmRNSOffer for Subscription - Update
19th Jan 201711:21 amRNSOffer for Subscription and Issue of Prospectus
16th Jan 201712:26 pmRNSVoluntary Interim Management Statement
12th Jan 20174:20 pmRNSResult of AGM
5th Jan 20175:44 pmRNSNet Asset Value(s)
3rd Jan 20174:17 pmRNSTotal Voting Rights
13th Dec 20164:47 pmRNSTransaction in Own Shares
6th Dec 20164:04 pmRNSNet Asset Value(s)
1st Dec 20164:31 pmRNSTotal Voting Rights
30th Nov 20163:35 pmRNSIntention to launch an Offer
24th Nov 20167:00 amRNSAnnual Financial Report
9th Nov 20165:15 pmRNSTransaction in Own Shares
8th Nov 201610:19 amRNSClosed Period Notification
4th Nov 20164:28 pmRNSNet Asset Value(s)
1st Nov 20169:57 amRNSTotal Voting Rights
13th Oct 20165:32 pmRNSTransaction in Own Shares
11th Oct 20167:00 amRNSNet Asset Value(s)
3rd Oct 20165:27 pmRNSTotal Voting Rights
7th Sep 20165:00 pmRNSTransaction in Own Shares
6th Sep 20163:10 pmRNSNet Asset Value(s)
5th Aug 201611:01 amRNSNet Asset Value(s)
1st Aug 201610:28 amRNSTotal Voting Rights
19th Jul 20168:48 amRNSVoluntary Interim Management Statement
15th Jul 201610:00 amRNSDirectorate Change
6th Jul 20164:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.